2Korba BA, Xie H, Wright KN,et al. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo[J].Hepatology,1996,23(5):958.
3Song SC, Soo-Sohn Y.Synthesis and hydrolytic properties of polyphosphazene/(diamine)platinum/saccharide conjugates[J]. J Controlled Release,1998,55(2-3):161.
4Hashida M, Akamatsu K, Nishikawa M, et al. Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting[J].Pharmazie,2000,55(3):202.
5Fiume L,Bassi B,Busi C,et al. Drug targeting in antiviral chemotherapy[J].Biochem Pharmcol,1986,35(6):967.
6Di-stefano G, Colonna FP, Bongini A, et al. Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatisis[J].Bichem Pharmacol,1997,54(3):357.
7Fiume L, Di-stefano G, Busi C, et al. Hepatotropic conjugate of adenine arabinoside monophosphated withlactosaminated poly-L-lysine. Synthesis of the carrier and pharmacological properties of the conjugate[J].J Hepatol,1997,26(2):253.
8Nishikawa M,Takemura S,Takakura Y,et al. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties[J].J Pharmacol Exp Ther,1998,287(1):408.
9Han JH, Oh YK, Kim DS. et al.Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier[J].Int J Pharm,1999,188(1):39.
10Torrani-Cerenzia M, Fiume L,de-Bernardi-Venon W, et al. Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects[J].Hepatology,1996, 23(4):657.
